International Patent: ACTIVIN RECEPTOR TYPE II A/B (ACTRIIA/B) ANTIBODIES

GENEVA, June 19 -- DIAGONAL THERAPEUTICS INC. filed a patent application (US2025/050346) for “ACTIVIN RECEPTOR TYPE II A/B (ACTRIIA/B) ANTIBODIES”. With publication no. WO/2026/080757, here are the other details related to the patent application:

Kind: Later publication of international search report [A3]

IPC: C07K 16/28

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....